Stephen Chapman
Chief Executive Officer at NATERA, INC.
Net worth: 21 M $ as of 2024-03-30
Profile
Currently, Stephen Chapman occupies the position of President, Chief Executive Officer & Director at Natera, Inc. In his past career Mr. Chapman held the position of Regional Manager at Genzyme Corp. and Principal at the University of California, Los Angeles. He received an undergraduate degree from the University of California, Los Angeles.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
NATERA, INC.
0.19% | 2024-03-27 | 234,526 ( 0.19% ) | 21 M $ | 2024-03-30 |
Stephen Chapman active positions
| Companies | Position | Start |
|---|---|---|
| NATERA, INC. | Chief Executive Officer | 2019-01-01 |
Former positions of Stephen Chapman
| Companies | Position | End |
|---|---|---|
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 2009-12-31 |
| University of California, Los Angeles | Corporate Officer/Principal | - |
Training of Stephen Chapman
| University of California, Los Angeles | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| NATERA, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Stephen Chapman
